Insulin and Oral Hypoglycemic Drug Overdose in Post-Mortem Investigations: A Literature Review.
Manetti AC, Visi G, Spina F, De Matteis A, Del Duca F, Turillazzi E, Maiese A.
Biomedicines. 2022 Nov 5;10(11):2823. doi: 10.3390/biomedicines10112823.
Treatment for calcium channel blocker poisoning: a systematic review.
St-Onge M, Dubé PA, Gosselin S, Guimont C, Godwin J, Archambault PM, Chauny JM, Frenette AJ, Darveau M, Le Sage N, Poitras J, Provencher J, Juurlink DN, Blais R.
Clin Toxicol (Phila). 2014 Nov;52(9):926-44. doi: 10.3109/15563650.2014.965827. Epub 2014 Oct 6.
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Vilsbøll T, Christensen M, Junker AE, Knop FK, Gluud LL.
BMJ. 2012 Jan 10;344:d7771. doi: 10.1136/bmj.d7771.
Oral Administration of Hoodia parviflora Alleviates Insulin Resistance and Nonalcoholic Steatohepatitis.
Mizrahi M, Ben Ya'acov A, Adar T, Levy Sklair M, Gaska S, Ilan Y.
J Med Food. 2019 Dec;22(12):1189-1198. doi: 10.1089/jmf.2019.0093. Epub 2019 Oct 21.
Treatment of sulfonylurea and insulin overdose.
Klein-Schwartz W, Stassinos GL, Isbister GK.
Br J Clin Pharmacol. 2016 Mar;81(3):496-504. doi: 10.1111/bcp.12822. Epub 2016 Jan 6.
ZOT-derived peptide and chitosan functionalized nanocarrier for oral delivery of protein drug.
Lee JH, Sahu A, Choi WI, Lee JY, Tae G.
Biomaterials. 2016 Oct;103:160-169. doi: 10.1016/j.biomaterials.2016.06.059. Epub 2016 Jun 27.
[Metformin-associated lactic acidosis].
Orban JC, Ghaddab A, Chatti O, Ichai C.
Ann Fr Anesth Reanim. 2006 Oct;25(10):1046-52. doi: 10.1016/j.annfar.2006.05.009. Epub 2006 Sep 26.
Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes.
Liu B, Yue Y, Yang Y, Jin Y.
PLoS One. 2016 Jan 19;11(1):e0147260. doi: 10.1371/journal.pone.0147260. eCollection 2016.
Recent advances in transdermal insulin delivery technology: A review.
Li H, Shi Y, Ding X, Zhen C, Lin G, Wang F, Tang B, Li X.
Int J Biol Macromol. 2024 Aug;274(Pt 2):133452. doi: 10.1016/j.ijbiomac.2024.133452. Epub 2024 Jun 26.
Efficacy and safety profile of exenatide once weekly compared with insulin once daily in Japanese patients with type 2 diabetes treated with oral antidiabetes drug(s): results from a 26-week, randomized, open-label, parallel-group, multicenter, noninferiority study.
Inagaki N, Atsumi Y, Oura T, Saito H, Imaoka T.
Clin Ther. 2012 Sep;34(9):1892-908.e1. doi: 10.1016/j.clinthera.2012.07.007. Epub 2012 Aug 9.
